Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat and cardiovascular risks in MASLD models. The drug duo works better together ...
Using two types of cardiovascular drugs together could help to treat fatty liver disease and reduce the number of severe cases. This is the finding of researchers from the University of Barcelona (UB) ...
Patients who start their blood pressure treatment with angiotensin receptor blocker (ARB) drugs continue with the same medicine to a greater extent than patients who start out with other drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results